Beneluxa: What are the Prospects for Collective Bargaining on Pharmaceutical Prices Given Diverse Health Technology Assessment Processes?
Crossref DOI link: https://doi.org/10.1007/s40273-019-00781-w
Published Online: 2019-03-08
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O’Mahony, James F.
Text and Data Mining valid from 2019-03-08
Article History
First Online: 8 March 2019
Compliance with Ethical Standards
:
: JFO’M has no conflicts of interest that are directly relevant to the content of this editorial.